The sodium-potassium blood pressure trial in children. Design, recruitment, and randomization: The children and adolescent blood pressure program

Orlando W Gomez-Marin, Ronald J. Prineas, Alan R. Sinaiko

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The Sodium-Potassium Blood Pressure Trial in Children (NaKS), is a clinical trial in a healthy, free living population of children and adolescents. It is designed to test the hypotheses that a reduction in dietary sodium and/or an increase in potassium intake will decrease the rate of rise in blood pressure during normal maturation in children and adolescents with high normal blood pressure. Screening was conducted in 19,452 students in grades 5-8 in Minneapolis and St. Paul between January 1986 and May 1987. After screening, 3,223 students were found to have blood pressures that fulfilled the initial eligibility criteria for the study, and of these, 643 (20.0%) attended the orientation meeting, i.e., the first clinic visit. A total of four clinic visits, designed to test the willingness and capability of the potential participants to comply with the study protocol were conducted prior to randomization. At the conclusion of the four prerandomization visits, 243 children (7.5% of the initially eligible children) agreed to be randomized to one of four trial groups: low-sodium diet; potassium supplement administration; placebo-treated control group; and a no-treatment control group (to test the effect of acclimatization on blood pressure measurements) that will not be seen after randomization until the 4-year termination of the study. The first participants was randomized into the study on June 17, 1986, and the last on December 29, 1987. The potassium and placebo capsules are administered double-masked. Participants will be examined and receive intervention instruction four times yearly for 4 years counted from the date of their randomization. All groups were comparable with regard to distribution of school district, sex, and race and with respect to baseline physical characteristics. Results from this study will provide information about the feasibility and effect of dietary intervention during childhood and adolescence on the prevention of essential hypertension.

Original languageEnglish
Pages (from-to)408-423
Number of pages16
JournalControlled Clinical Trials
Volume12
Issue number3
DOIs
StatePublished - Jan 1 1991
Externally publishedYes

Fingerprint

Random Allocation
Potassium
Sodium
Blood Pressure
Ambulatory Care
Placebos
Students
Dietary Sodium
Sodium-Restricted Diet
Control Groups
Acclimatization
Capsules
Clinical Trials
Hypertension
Population
Therapeutics

Keywords

  • children
  • Clinical trial
  • hypertension
  • potassium
  • sodium

ASJC Scopus subject areas

  • Pharmacology

Cite this

The sodium-potassium blood pressure trial in children. Design, recruitment, and randomization : The children and adolescent blood pressure program. / Gomez-Marin, Orlando W; Prineas, Ronald J.; Sinaiko, Alan R.

In: Controlled Clinical Trials, Vol. 12, No. 3, 01.01.1991, p. 408-423.

Research output: Contribution to journalArticle

@article{80a8c1e4d9114b2bab7230143e07cdbe,
title = "The sodium-potassium blood pressure trial in children. Design, recruitment, and randomization: The children and adolescent blood pressure program",
abstract = "The Sodium-Potassium Blood Pressure Trial in Children (NaKS), is a clinical trial in a healthy, free living population of children and adolescents. It is designed to test the hypotheses that a reduction in dietary sodium and/or an increase in potassium intake will decrease the rate of rise in blood pressure during normal maturation in children and adolescents with high normal blood pressure. Screening was conducted in 19,452 students in grades 5-8 in Minneapolis and St. Paul between January 1986 and May 1987. After screening, 3,223 students were found to have blood pressures that fulfilled the initial eligibility criteria for the study, and of these, 643 (20.0{\%}) attended the orientation meeting, i.e., the first clinic visit. A total of four clinic visits, designed to test the willingness and capability of the potential participants to comply with the study protocol were conducted prior to randomization. At the conclusion of the four prerandomization visits, 243 children (7.5{\%} of the initially eligible children) agreed to be randomized to one of four trial groups: low-sodium diet; potassium supplement administration; placebo-treated control group; and a no-treatment control group (to test the effect of acclimatization on blood pressure measurements) that will not be seen after randomization until the 4-year termination of the study. The first participants was randomized into the study on June 17, 1986, and the last on December 29, 1987. The potassium and placebo capsules are administered double-masked. Participants will be examined and receive intervention instruction four times yearly for 4 years counted from the date of their randomization. All groups were comparable with regard to distribution of school district, sex, and race and with respect to baseline physical characteristics. Results from this study will provide information about the feasibility and effect of dietary intervention during childhood and adolescence on the prevention of essential hypertension.",
keywords = "children, Clinical trial, hypertension, potassium, sodium",
author = "Gomez-Marin, {Orlando W} and Prineas, {Ronald J.} and Sinaiko, {Alan R.}",
year = "1991",
month = "1",
day = "1",
doi = "10.1016/0197-2456(91)90020-M",
language = "English",
volume = "12",
pages = "408--423",
journal = "Controlled Clinical Trials",
issn = "0197-2456",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - The sodium-potassium blood pressure trial in children. Design, recruitment, and randomization

T2 - The children and adolescent blood pressure program

AU - Gomez-Marin, Orlando W

AU - Prineas, Ronald J.

AU - Sinaiko, Alan R.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - The Sodium-Potassium Blood Pressure Trial in Children (NaKS), is a clinical trial in a healthy, free living population of children and adolescents. It is designed to test the hypotheses that a reduction in dietary sodium and/or an increase in potassium intake will decrease the rate of rise in blood pressure during normal maturation in children and adolescents with high normal blood pressure. Screening was conducted in 19,452 students in grades 5-8 in Minneapolis and St. Paul between January 1986 and May 1987. After screening, 3,223 students were found to have blood pressures that fulfilled the initial eligibility criteria for the study, and of these, 643 (20.0%) attended the orientation meeting, i.e., the first clinic visit. A total of four clinic visits, designed to test the willingness and capability of the potential participants to comply with the study protocol were conducted prior to randomization. At the conclusion of the four prerandomization visits, 243 children (7.5% of the initially eligible children) agreed to be randomized to one of four trial groups: low-sodium diet; potassium supplement administration; placebo-treated control group; and a no-treatment control group (to test the effect of acclimatization on blood pressure measurements) that will not be seen after randomization until the 4-year termination of the study. The first participants was randomized into the study on June 17, 1986, and the last on December 29, 1987. The potassium and placebo capsules are administered double-masked. Participants will be examined and receive intervention instruction four times yearly for 4 years counted from the date of their randomization. All groups were comparable with regard to distribution of school district, sex, and race and with respect to baseline physical characteristics. Results from this study will provide information about the feasibility and effect of dietary intervention during childhood and adolescence on the prevention of essential hypertension.

AB - The Sodium-Potassium Blood Pressure Trial in Children (NaKS), is a clinical trial in a healthy, free living population of children and adolescents. It is designed to test the hypotheses that a reduction in dietary sodium and/or an increase in potassium intake will decrease the rate of rise in blood pressure during normal maturation in children and adolescents with high normal blood pressure. Screening was conducted in 19,452 students in grades 5-8 in Minneapolis and St. Paul between January 1986 and May 1987. After screening, 3,223 students were found to have blood pressures that fulfilled the initial eligibility criteria for the study, and of these, 643 (20.0%) attended the orientation meeting, i.e., the first clinic visit. A total of four clinic visits, designed to test the willingness and capability of the potential participants to comply with the study protocol were conducted prior to randomization. At the conclusion of the four prerandomization visits, 243 children (7.5% of the initially eligible children) agreed to be randomized to one of four trial groups: low-sodium diet; potassium supplement administration; placebo-treated control group; and a no-treatment control group (to test the effect of acclimatization on blood pressure measurements) that will not be seen after randomization until the 4-year termination of the study. The first participants was randomized into the study on June 17, 1986, and the last on December 29, 1987. The potassium and placebo capsules are administered double-masked. Participants will be examined and receive intervention instruction four times yearly for 4 years counted from the date of their randomization. All groups were comparable with regard to distribution of school district, sex, and race and with respect to baseline physical characteristics. Results from this study will provide information about the feasibility and effect of dietary intervention during childhood and adolescence on the prevention of essential hypertension.

KW - children

KW - Clinical trial

KW - hypertension

KW - potassium

KW - sodium

UR - http://www.scopus.com/inward/record.url?scp=0025890450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025890450&partnerID=8YFLogxK

U2 - 10.1016/0197-2456(91)90020-M

DO - 10.1016/0197-2456(91)90020-M

M3 - Article

C2 - 1651211

AN - SCOPUS:0025890450

VL - 12

SP - 408

EP - 423

JO - Controlled Clinical Trials

JF - Controlled Clinical Trials

SN - 0197-2456

IS - 3

ER -